IS

Principles of OT in Mental Health - Medications and Treatments

Introduction

  • Historical Context

    • Until the 1950s, individuals with severe mental health disorders lacked effective medical treatment.

    • The introduction of psychotropic medications allowed for the management of symptoms such as hallucinations.

  • Understanding Signs vs Symptoms

    • Signs: Observable characteristics identified by a medical professional, measured through assessments such as body temperature, weight fluctuations, or blood pressure readings.

    • Symptoms: Experiences or feelings reported by the client.

Psychotropic Medications

  • Definition

    • Psychotropic medications are defined as "mind-changing" drugs that alter brain functions.

  • OTP Interaction

    • Occupational therapy practitioners (OTPs) must observe how these medications impact clients' engagement in daily activities.

  • Research

    • Ongoing investigations aim to identify the most effective and efficient medications.

Mechanisms of Psychotropic Drugs

  • Impact on Neurotransmitters

    • These drugs affect neurotransmitter levels, altering critical brain chemicals such as:

    • Dopamine

    • Norepinephrine

    • Serotonin

  • Specific Actions

    • Medications for schizophrenia target dopamine receptors.

    • Antidepressants modify serotonin levels along with other neurotransmitters.

    • Medications are primarily administered orally (tablets, capsules, liquids) or through injections to ensure adherence.

Types of Psychotropic Medications and Their Side Effects

  • Antipsychotic Drugs

    • Commonly prescribed for schizophrenia and psychotic disorders.

    • Help manage hallucinations and improve reality contact; can reduce aggressive behaviors.

    • Adverse Effects

    • Discussed are extrapyramidal side effects (EPS) like sunburn, dry mouth, and blurry vision.

    • Disadvantages include high costs and difficulty performing activities of daily living (ADLs).

    • New Research: Ongoing trials for third-generation antipsychotics address both positive and negative symptoms during acute schizophrenia episodes.

  • Antiparkinsonian Drugs

    • Typically prescribed alongside first-generation antipsychotic medications.

  • Antidepressant Drugs

    • Consist of five classes, each affecting neurotransmitters differently.

    • Black Box Warning: Due to the higher risk of suicide among individuals under 25, the FDA mandates warnings on all antidepressants.

    • Onset of full effect may take up to three weeks, and certain dietary restrictions are essential (especially for MAOIs).

  • Mood Stabilizers

    • Reduce mood swings and manage mania.

    • Lithium, a common mood stabilizer, is toxic and necessitates regular blood monitoring for side effects like neurologic and renal dysfunction.

  • Anxiolytic Drugs

    • Used for anxiety and panic disorders; cause sedation.

    • May assist with agitation and alcohol withdrawal symptoms.

  • ADHD Medications

    • Monitor potential side effects, including impaired growth, tics, and increased risk of suicidal thoughts.

Consumer Concerns Related to Medications

  • Adherence Issues

    • Nonadherence rate exceeds 50% within the first year due to feelings of unnaturalness or inconvenience.

    • Side effects often deter adherence.

  • Client Factors

    • Conditions such as arthritis, sensory issues, and cognitive challenges affect medication compliance.

    • Family opinions on side effects can undermine adherence.

Roles of the OTP

  • Observing and Reporting Functional Level

    • OTPs assess function pre- and post-medication initiation.

    • Educate clients on the benefits of medications.

  • Issues of Adherence

    • Clients may alter medication regimens to mitigate side effects or maintain symptom balance.

    • Risk of relapse increases with the non-compliance to medical advice.

    • OTPs need to observe changes that affect functional abilities and communicate these to medical providers.

  • Management of Side Effects

    • Strategies outlined in Table 8.7 assist clients with side effects.

    • Discussions regarding risks of relapse should be facilitated.

  • Safety Concerns

    • Some medications may impair motor skills related to driving.

  • Medication Education and Management

    • The recovery model encourages clients to take charge of their recovery process.

Other Biologic Treatments

  • Electroconvulsive Therapy (ECT)

    • Incorrectly referred to as "shock therapy"; effectively alleviates severe depression in 80-90% of individuals who do not respond to medications.

    • Administered over 8-12 sessions, every other day over several weeks.

  • Psychosurgery

    • Historically utilized procedures like prefrontal lobotomy to relieve severe mental symptoms.

    • Gamma radiation surgery is explored for OCD symptom relief.

  • Somatic Therapies

    • Include vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), and magnetic seizure therapy.

    • Bright Light Therapy (BLT): Utilizes controlled UV light exposure for 30-45 minutes daily to treat depression, contraindicated for photosensitive patients.

Herbal and Alternative Therapies

  • Kava Kava

    • Used to alleviate anxiety.

  • St. John’s Wort

    • Utilized for depression treatment in Europe.

  • Valerian

    • Demonstrated positive effects on insomnia.

  • Precaution

    • Consult with a healthcare provider before initiating any alternative therapies.

Concerns Related to the Internet

  • Internet Resource Reliability

    • Not all online information about medications is trustworthy; clients should consult physicians about their medications.

  • Box 8.2: Recommended reputable internet sources for drug information.

Detoxification

  • OTP Professional Qualities

    • Should display supportive and nonjudgmental attitudes, cultivate empathy and calmness, establish trust through consistent interactions, and maintain a confident and knowledgeable demeanor.

  • Signs and Symptoms of Withdrawal

    • Medical assessments (blood, urine tests) identify withdrawal states.

    • Table 8.8 identifies withdrawal signs and symptoms but emphasizes variability among individuals and co-occurrence of mental disorders during withdrawal.

Assessment During Detoxification

  • Initial Evaluation

    • Conducted by medical staff encompassing a comprehensive health history, current mental status, neurologic findings, vital signs, substance abuse history, and toxicological reports.

  • Follow-Up by OTPs

    • Evaluates cultural habits, educational backgrounds, living conditions, and social interaction skills among others.

Intervention Considerations During Detoxification

  • Nutrition and Mealtime

    • Establishing meal consistency and nutritious choices aids in forming healthy habits.

    • Sensory experiences related to mealtimes (visual, olfactory, gustatory) should be considered as they may overwhelm clients.

  • Emotional Support

    • OTPs assist clients in navigating the range of emotions experienced during detox.

    • Encourage connection to social support systems like 12-step programs.

Transition Planning

  • OTPs are responsible for formulating a transition plan that includes community resources, family assistance, and vocational as well as educational pursuits.